...
首页> 外文期刊>The Journal of Nuclear Medicine >Impact of Tumor Size and Tracer Uptake Heterogeneity in 18F-FDG PET and CT Non-Small Cell Lung Cancer Tumor Delineation.
【24h】

Impact of Tumor Size and Tracer Uptake Heterogeneity in 18F-FDG PET and CT Non-Small Cell Lung Cancer Tumor Delineation.

机译:肿瘤大小和示踪剂摄取异质性对18F-FDG PET和CT非小细胞肺癌肿瘤轮廓的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

The objectives of this study were to investigate the relationship between CT- and (18)F-FDG PET-based tumor volumes in non-small cell lung cancer (NSCLC) and the impact of tumor size and uptake heterogeneity on various approaches to delineating uptake on PET images. METHODS: Twenty-five NSCLC cancer patients with (18)F-FDG PET/CT were considered. Seventeen underwent surgical resection of their tumor, and the maximum diameter was measured. Two observers manually delineated the tumors on the CT images and the tumor uptake on the corresponding PET images, using a fixed threshold at 50% of the maximum (T(50)), an adaptive threshold methodology, and the fuzzy locally adaptive Bayesian (FLAB) algorithm. Maximum diameters of the delineated volumes were compared with the histopathology reference when available. The volumes of the tumors were compared, and correlations between the anatomic volume and PET uptake heterogeneity and the differences between delineations were investigated. RESULTS: All maximum diameters measured on PET and CT images significantly correlated with the histopathology reference (r > 0.89, P < 0.0001). Significant differences were observed among the approaches: CT delineation resulted in large overestimation (+32% +/- 37%), whereas all delineations on PET images resulted in underestimation (from -15% +/- 17% for T(50) to -4% +/- 8% for FLAB) except manual delineation (+8% +/- 17%). Overall, CT volumes were significantly larger than PET volumes (55 +/- 74 cm(3) for CT vs. from 18 +/- 25 to 47 +/- 76 cm(3) for PET). A significant correlation was found between anatomic tumor size and heterogeneity (larger lesions were more heterogeneous). Finally, the more heterogeneous the tumor uptake, the larger was the underestimation of PET volumes by threshold-based techniques. CONCLUSION: Volumes based on CT images were larger than those based on PET images. Tumor size and tracer uptake heterogeneity have an impact on threshold-based methods, which should not be used for the delineation of cases of large heterogeneous NSCLC, as these methods tend to largely underestimate the spatial extent of the functional tumor in such cases. For an accurate delineation of PET volumes in NSCLC, advanced image segmentation algorithms able to deal with tracer uptake heterogeneity should be preferred.
机译:这项研究的目的是调查非小细胞肺癌(NSCLC)中基于CT和(18)F-FDG PET的肿瘤体积之间的关系以及肿瘤大小和摄取异质性对描述摄取的各种方法的影响在PET图像上。方法:25例非小细胞肺癌(18)F-FDG PET / CT患者。对其肿瘤进行手术切除的有十七名,并测量了最大直径。两名观察员使用固定阈值(最大值的50%)(T(50)),自适应阈值方法和模糊局部自适应贝叶斯方法(FLAB)手动在CT图像上描绘肿瘤并在相应的PET图像上描绘肿瘤摄取)算法。划定体积的最大直径与组织病理学参考(如果有)进行比较。比较了肿瘤的体积,并研究了解剖体积与PET摄取异质性之间的相关性以及轮廓之间的差异。结果:在PET和CT图像上测得的所有最大直径均与组织病理学参考显着相关(r> 0.89,P <0.0001)。在这些方法之间观察到显着差异:CT描绘导致高估(+ 32%+/- 37%),而PET图像上的所有描绘导致被低估(T(50)从-15%+/- 17%到FLAB为-4%+/- 8%)(手动划界除外)(+ 8%+/- 17%)。总体而言,CT体积明显大于PET体积(CT为55 +/- 74 cm(3),而PET为18 +/- 25至47 +/- 76 cm(3))。在解剖肿瘤大小和异质性之间发现了显着相关性(更大的病变更加异质)。最后,肿瘤吸收越不均匀,基于阈值的技术对PET体积的低估就越大。结论:基于CT图像的体积大于基于PET图像的体积。肿瘤大小和示踪剂摄取异质性会对基于阈值的方法产生影响,该方法不应用于描述大型异质性NSCLC病例,因为这些方法往往会大大低估此类情况下功能性肿瘤的空间范围。为了准确描绘NSCLC中的PET体积,应该首选能够处理示踪剂摄取异质性的高级图像分割算法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号